Oxygenta Pharmaceutical Limited (BOM:524636)
51.46
+3.90 (8.20%)
At close: Jun 18, 2026
Oxygenta Pharmaceutical Market Cap
Oxygenta Pharmaceutical has a market cap or net worth of 1.9 billion as of June 18, 2026. Its market cap has decreased by -43.48% in one year.
Market Cap
1.90B
Enterprise Value
2.98B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
51.46
Market Cap Chart
Since June 4, 1997, Oxygenta Pharmaceutical's market cap has increased from 7.22M to 1.90B, an increase of 26,271.80%. That is a compound annual growth rate of 21.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.90B | -7.76% |
| Dec 31, 2025 | 2.06B | -36.22% |
| Dec 31, 2024 | 3.23B | 210.06% |
| Dec 29, 2023 | 1.04B | 159.15% |
| Dec 30, 2022 | 402.61M | 2.53% |
| Dec 31, 2021 | 392.67M | 307.32% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BDH Industries | 2.52B |
| Kerala Ayurveda | 2.50B |
| Ambalal Sarabhai Enterprises | 2.45B |
| Sat Kartar Life | 2.44B |
| Sanjivani Paranteral | 1.82B |
| Coral Laboratories | 1.79B |
| Speciality Medicines | 1.76B |
| Bio Medica Laboratories | 1.68B |